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Abstract: Ochratoxins, and particularly ochratoxin A (OTA), are toxic fungal-derived contaminants
of food and other agricultural products. Growing evidence supports the degradation of OTA by
chemical, enzymatic and/or microbial means as a potential approach to remove this mycotoxin from
food products. In particular, hydrolysis of OTA to ochratoxin α (OTα) and phenylalanine is the
presumptive product of degradation in most cases. In the current study, we employed the zebrafish
(Danio rerio) embryo, as a model of vertebrate development to evaluate, the teratogenicity of OTA
and OTα. These studies show that OTA is potently active in the zebrafish embryo toxicity assay
(ZETA), and that toxicity is both concentration- and time-dependent with discernible and quantifiable
developmental toxicity observed at nanomolar concentrations. On the other hand, OTα had no
significant effect on embryo development at all concentrations tested supporting a decreased
toxicity of this degradation product. Taken together, these results suggest that ZETA is a useful, and
highly sensitive, tool for evaluating OTA toxicity, as well as its degradation products, toward
development of effective detoxification strategies. Specifically, the results obtained with ZETA,
in the present study, further demonstrate the toxicity of OTA, and support its degradation via
hydrolysis to OTα as an effective means of detoxification.
Keywords: mycotoxins; ochratoxin A; ochratoxin α; teratogenicity; zebrafish; detoxification

1. Introduction
Ochratoxins are a family of mycotoxins produced by several fungal genera, including Penicillium
and Aspergillus, and associated with contamination of various foods (e.g., fruits, grains, meats) and
other agricultural products (e.g., wine, coffee) [1]. In particular, ochratoxin A (OTA; Figure 1) is, by far,
the most prevalent, and generally considered the most toxic, variant of the family [2]. Structurally
speaking, OTA is a chlorinated dihydroisocoumarin specifically linked, via an amide-bond, to
phenylalanine. Toxicologically, OTA has been particularly linked to nephrotoxicity, and although
found to a lesser extent in other tissues, it has been suggested [3,4] that specific transporters may be
involved in the high accumulation of the toxin in kidneys. Consequently, exposure to OTA manifests
in a recognized and well-described nephropathy, particularly in certain livestock [5]. Several studies
have implicated oxidative stress in the toxicity of OTA including, in particular, a role of the nuclear
factor, Nrf2 [4,6,7]. In addition to nephrotoxicity, however, other studies have indicated that OTA is
carcinogenic via both genotoxic and non-genotoxic mechanisms [4,8–11]. Notably, ochratoxins have
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been proposed to be involved in so-called Balkan Endemic Nephropathy, an interstitial
nephritis—progressing to cancer in about 50% of cases—that is limited geographically to rural
farming communities along the Danube River [12–14]. Despite demonstrated toxicity in various
animal models with respect to nephrotoxicity and carcinogenicity, a link to human health remains,
in fact, unconfirmed [4].
Several recent studies have investigated the possibility of chemical, enzymatic or microbial
degradation of OTA as a means of detoxification in food and agricultural products [15]. It has been
observed, for example, that OTA (as a contaminant of grains and other feeds) is effectively eliminated
by microflora—and particularly protozoans—of ruminants, and is not, consequently, found in milk
of these exposed animals [16], whereas non-ruminants, including humans, can transfer the toxin to
milk [17,18]. These and other studies, therefore, suggest a role of microbial degradation of the toxin;
in fact, numerous studies have identified OTA-degrading bacteria, fungi and protozoans as recently
reviewed by Abrunhosa et al. [19]. Specifically, the primary pathway of enzymatic degradation
expected and, indeed, observed in studies [19–21] is the hydrolytic cleavage of the amide bond within
OTA, resulting in the production of so-called ochratoxin α (OTα), and phenylalanine (Figure 1).
Several studies have indicated that OTα is relatively less toxic in various models including both
cell-based [22] and animal models [21], and suggest that this pathway for chemical degradation of
OTA represent an effective means of detoxification.
The present study specifically employed the zebrafish (Danio rerio) embryo, as a vertebrate
model of teratogenicity (i.e., developmental toxicity), to evaluate both OTA and its presumptive
degradation product, OTα. The zebrafish system has emerged as an important toxicological model,
and embryonic stages, in particular, present numerous scorable endpoints (e.g., morphological
deformities, hatching, behavioral responses) relevant to evaluation of teratogenicity. Accordingly,
the zebrafish embryo toxicity assay (ZETA) has been effectively utilized in various forms to
investigate a wide range of environmental contaminants, including microbial toxins [23]. Moreover,
as a well characterized vertebrate system, ZETA can, thereby, be employed as a proxy for understanding
potential toxicity to higher animals including humans. As such, evaluation of the teratogenicity of
OTA and OTα represents a step toward further understanding the proposed microbial/chemical
degradation pathway as a means of detoxifying ochratoxins.

Figure 1. Hydrolysis of the amide bond in OTA (1) to yield OTα (2) and phenylalanine as considered
the primary degradation/detoxification pathway for ochratoxins.
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2. Experimental Section
2.1. Chemicals
Ochratoxin A was purchased from a commercial source (Sigma-Aldrich, St. Louis, MO, USA).
Ochratoxin α was synthesized by hydrolysis of OTA as modified from Xiao et al. [24]. Briefly,
OTA (1.7 mg) was refluxed in 6 N HCl (6 mL) for 72 h, and liquid-liquid extraction with chloroform
was used to recover the product (0.5 mg of presumptive OTα) of the hydrolysis. The hydrolysis
reaction was followed by normal-phase thin-layer chromatography (TLC) using toluene/EtOAc/90%
formic acid (5:4:1) as a solvent system [25], and fluorescence under long-wave UV (i.e., 366 nm) for
detection; the identity of OTα was subsequently confirmed by previously described HPLC-FL and
LC-MS methods [26,27] using a commercially available analytical standard of OTα (Romer Labs,
Union, MO, USA). All other chemicals and reagents were purchased from either VWR Scientific
(Radnor, PA, USA), or Sigma-Aldrich (St. Louis, MO, USA).
2.2. Zebrafish Embryo Toxicity Assay
The zebrafish embryo teratogenicity assay (ZETA) was generally conducted as previously
described [23]. Briefly, chemical treatments (as MeOH solution in minimal volumes), along with
solvent (i.e., MeOH) controls, were added in triplicate to wells of 24-well polypropylene plates
(Evergreen Scientific, Los Angeles, CA, USA), and allowed to evaporate to dryness. Subsequently,
1 mL of E3 medium [28] was added to each well, and five zebrafish embryos (≤2 hours post-fertilization
[hpf], 4–32 cell stage) were transferred to each test well. Compounds were tested at a range of
concentrations (based on preliminary studies) from 0.05 to 2.5 µM; specifically, OTA was tested at
0.05, 0.1, 0.25, 0.5, 1, 2 and 2.5 µM, whereas OTα was tested at 0.1, 0.25, 0.5, 1 and 2.5 µM due to
relatively limited amount of compound. Embryos were subsequently observed daily using a
dissecting microscope until 5 days post-fertilization (dpf) when hatching of eleutheroembryos was
typically completed, and prior to larval stages (i.e., ≥7 dpf). All breeding and bioassays involving
zebrafish were conducted under protocols approved by the FIU Institutional Animal Care and Use
Committee (IACUC), and performed by trained investigators.
2.3. Data Analysis
Percent mortality was calculated for each replicate (n = 3), and relative teratogenicity was,
likewise, calculated as the percent deformed embryos per total number of live embryos in each replicate,
for both OTA and OTα at each test concentration (see Section 2.2.) and each daily observation time
point (1, 2, 3, 4 and 5 dpf). Relative mortality and developmental toxicity at each observational time
point was calculated, respectively, as concentration for 50% lethality (LC50), and effective concentration
(EC50) for teratogenicity, using GraphPad software (La Jolla, CA, USA). Relative (i.e., average)
mortality and development toxicity at each concentration and observational time point was evaluated
by analysis of variance (ANOVA) using AnalystSoft software (Walnut, CA, USA) to determine statistical
significance relative to negative (i.e., untreated embryo) controls.
3. Results and Discussion
3.1. Synthesis of OTα by Hydrolysis of OTA
Ochratoxin α as the presumptive degradation product of OTA was synthesized by the
previously described hydrolysis [24]. The reaction was evaluated by HPLC-FL and LC-MS to confirm
hydrolysis (and presence of OTα. These analyses suggest essentially complete hydrolysis of OTA to
OTα (Figure 2). The identity of the hydrolysis product was confirmed by mass spectrometry (i.e.,
LC-MS), specifically based on the observation of the OTA molecular ion (MH+ 255 m/z), and mass
transition of the precursor to daughter (255 > 211 m/z), as well as comparison to a reference standard
of OTα (Figure 2). Notably, a small amount of OTα was also observed in the standard of OTA as a
3
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presumptive degradation product. The resulting OTα (i.e., hydrolysis product) was used for
subsequent comparative toxicology studies.

Figure 2. Chromatogram (HPLC-FL) of the hydrolysis of OTA to OTα. Shown are OTA standard (A),
and subsequent hydrolysis product (B); for comparison, the chromatogram of the reference standard
of OTα (C) as the presumptive hydrolysis product is shown. The identity of hydrolysis product was
confirmed as OTα by LC-MS (see inset for pane (B)) based on the molecular ion (MH+ 255 m/z, Full Scan)
and Selected Reaction Monitoring (SRM) mass transition (255 > 211 m/z). Apparent degradation to
OTα was also observed in the OTA standard (see (A)).

3.2. Teratogenicity of OTA and OTα
Ochratoxin A and its presumptive degradation product, OTα were evaluated for teratogenicity
by ZETA. Consistent with toxicity in other models, OTA was potently toxic to zebrafish embryo
development (Figures 3–5). Embryos exposed to concentrations as low as 1 µM developed
abnormally with frequencies significantly higher than controls by 1 dpf (Figure 3). This development
toxicity increased progressively at subsequent time-points (e.g., 2, 4 and 5 dpf) observed.
For example, all embryos exposed to OTA were discernibly deformed at concentrations of 1, 0.25 and
0.1 µM by 2, 4 and 5 dpf, respectively, and significant teratogenicity was, furthermore, observed at
even the lowest concentration tested (0.05 µM) by 5 dpf (Figure 3). Notably, no difference was
observed between 2 and 3 dpf (data not shown). Likewise, EC50 values for teratogenicity of OTA
decreased over exposure time from 1 to 5 dpf, respectively, from 0.25 to 0.02 µM.

4
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Figure 3. Dose and time dependence of OTA and OTα teratogenicity in ZETA. Shown are averages
and standard deviations (n = 3) of the percent deformed embryos (5 per well/replicate) at a range of
concentrations at 1 (A), 2 (B), 4 (C) and 5 (D) days post-fertilization. Activity is statistically compared
to solvent (i.e., “MeOH”) only controls (n = 3); statistically significant differences are indicated at:
(a) p < 0.05; (b) p < 0.01; and (c) p < 0.005. No significant difference was observed between MeOH-only
and untreated (“E3” i.e., test medium alone) controls as shown.

5

Toxins 2016, 8, 40

Figure 4. Representative development dysfunction of zebrafish embryos exposed to OTA and OTα at
1 and 3 days post-fertilization. Shown are embryos exposed to 0.5 µM OTA (A) compared to
solvent (i.e., MeOH) only controls (B) at 1 dpf; and embryos exposed to 0.5 µM (C) and 0.1 µM (D)
OTA, and 2.5 µM OTα (E), compared to solvent, i.e., MeOH, only controls (F), at 3 dpf.

Developmental dysfunction of zebrafish exposed to OTA was characterized by discernible
deformities, reduced growth and hatching rates, and lethality. At the highest concentrations (≥0.5 µM),
OTA was generally lethal by 2 dpf, and development of surviving embryos was severely retarded
(Figure 4). At concentrations as low as 0.05 µM, clear morphological deformities were observed by
4–5 dpf, specifically characterized by reduced growth rates, craniofacial deformities, curvature of the
body axis and edemas (Figure 5), as well as a dose-dependent reduction in hatching rates (Figure 6).

6
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Figure 5. Representative development dysfunction of zebrafish embryos exposed to OTA and OTα at
5 days post-fertilization. Shown are embryos exposed to 0.5 µM (A), 0.25 µM (B), 0.1 µM (C) and
0.05 µM (D) OTA, as well as 2.5 µM OTα (E), compared to solvent-only (i.e., MeOH) controls (F).

Teratogenicity of OTA in the present study quantitatively and qualitatively resembles that
previously observed. In prior, non-peer reviewed reports [29], developmental toxicity in the zebrafish,
including edemas and malformation of fins and eyes, was observed at concentrations as low 0.6 µM
and 0.2 µM by 2 and 6 dpf, respectively. More generally, dose and time dependence of teratogenicity
has been previous observed in other models [2,30]. Similar to the zebrafish, OTA was found, for
example, in the amphibian, i.e., Xenopus laevis, model (i.e., “Fetal Embryo Toxicity Assay Xenopus”
(FETAX)), to be teratogenic, specifically resulting in various craniofacial deformities [2] as observed
in the present study. This manifestation of developmental toxicity (i.e., craniofacial deformities) has,
in fact, been observed in a wide range of vertebrate models including rats [31], mice [32], hamsters [33]
and chicken [30]. Studies in the FETAX system suggest EC50 values of approximately 60 nM compared
to discernible developmental toxicity at levels <20 nM in ZETA. Moreover, the numerous practical
advantages of the zebrafish model (e.g., high fecundity, completely sequenced genome, high-throughput
potential, etc.), along with this sensitivity, suggest that ZETA is a powerful toxicological system for
evaluating toxicity of OTA and its metabolites (and other degradation products).
7
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Figure 6. Effect of OTA on zebrafish hatching rate. Shown, for a representative exposure, is percent
unhatched eggs/embryos at 5 days post-fertilization for 0.25, 0.1 and 0.05 µM OTA compared to
solvent only (“MeOH”) and solvent-free medium (“E3”). At OTA > 0.25 µM, all embryos were dead
or severely deformed (and not hatched). Error bars represent standard deviations (n = 2).

Compared to teratogenicity, significant lethality was observed at higher concentrations of OTA,
and later stages of development (Figure 7). No statistically significant mortality was observed at
1 dpf, although slightly higher average mortalities were observed at the highest concentrations (1–2.5 µM)
of the toxin. By 2 dpf, however, significant mortality among embryos exposed to OTA was observed
at concentrations as low as 0.5 µM OTA. Percent mortality, however, at later stages (4 and 5 dpf) did
not increase (data not shown), and significant mortality was not observed during the course of
exposures at the lower test concentrations (≤0.25 µM) despite significantly higher rates of deformity
in these treatments. In fact, calculated LC50 values were nearly an order of magnitude greater than
effective concentrations (i.e., EC50) for developmental deformities at, for example, both 1 dpf (2.14 and
0.25 µM, respectively) and 4 dpf (0.25 and 0.03 µM, respectively).
Taken together, these results generally support a high (i.e., nanomolar concentration) sensitivity
of zebrafish teratogenicity (compared to lethality) as a toxicological marker for OTA toxicity, and
therefore, a potentially important utility of this biological system for future studies. Indeed, the
observed sensitivity of ZETA (e.g., EC50 ≥ 20 nM) approaches the current regulatory food safety limits
for OTA including, for example, European Union limits set for various agricultural and food products
which are typically in the range of 1–80 ppb, i.e., ~2.5 to 200 nM [34].
In contrast to OTA, embryos exposed to OTα showed neither teratogenicity, nor mortality,
significantly different from that of negative controls (i.e., solvent only, untreated) over 5 dpf.
Generally speaking, an average of 19% frequency of deformity was observed for all concentrations
tested (≤2.5 µM), and exposure/developmental times (1–5 dpf) evaluated, for OTα-exposed embryos,
corresponding to <1 discernibly deformed embryo out of 5 tested per replicate (n = 3), which was not
significantly different from either solvent (i.e., MeOH) only control, or untreated, embryos (Figure 3).
Furthermore, no concentration or time-dependent trends were observed for embryos exposed to
OTα (Figure 3). Similar to deformity, no significantly different percent mortalities were observed over
range of concentrations tested at any observational time points for OTα compared to controls (Figure 7).
Taken together, these finding suggest that hydrolysis of OTA to OTα, as the presumptive degradation
product of OTA (discussed below), effectively detoxifies the compound with respect to teratogenicity
and mortality in ZETA.

8
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Figure 7. Dose and time dependence of OTA and OTα lethality in ZETA. Shown are averages and
standard deviations (n = 3) of the percent mortality (5 per well/replicate) at a range of concentrations
at 1 (A), 2 (B) and 3 (C) days post-fertilization. Activity is statistically compared to solvent (i.e., MeOH)
only controls (n = 3); statistically significant difference are indicated at: (a) p < 0.05; (b) p < 0.01; and
(c) p < 0.005. No significant difference was observed between MeOH-only and untreated (i.e., E3 test
medium alone) controls as shown.

Several previous studies have investigated the potential degradation of OTA via chemical,
enzymatic or microbial metabolic means [19], specifically as a means of removing the toxin from
agricultural products. Generally speaking, these studies have indicated that hydrolysis of OTA to
OTα and phenylalanine (Figure 1) is the most likely, and most frequently observed, degradation
pathway [19–21]. Recently, for example, employing the bacterial species Cupriavidus basilensis,
Ferenczi et al. [21] demonstrated apparent hydrolysis of OTA to OTα, and consequent detoxification
as evidenced by comparative toxicological studies in a mouse model of nephrotoxicity. Indeed, about
16 species of bacteria are known to have OTA-degrading capability, along with protozoans, yeasts
and filamentous fungi and even some plants [19–21]. In essentially all cases in which degradation
was characterized, cleavage of the amide bond to produce OTα and phenylalanine (Figure 1) was
reported. The enzymes responsible for the hydrolytic cleavage have, however, varied and included,
carboxypeptidases, protease and even lipases [19].
Although the present results suggest that hydrolysis of OTA to OTα is an effective means of
detoxification, several studies have, in fact, suggested alternative degradation routes for OTA [19,35–37].
In particular, a hypothetical degradation via opening of the lactone ring has been proposed [35,37],
and studies demonstrated toxicity of the open-ring OTA in a rats, although similar toxicity of the
proposed degradation product in other mammal (i.e., mouse) models—as well as other biological
activity (i.e., antibacterial)—was not observed [37]. Most recently, an amide of OTα was observed,
following light and heat treatment of OTA; however, similar to OTα, the amide was also found to be
generally non-toxic in cell-based assays [36]. That said, continued evaluation of metabolic products,
and specifically the toxicity of the products of chemical or enzymatic degradation, is needed.
9
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4. Conclusions
The results presented here suggest that the zebrafish is an effective model for evaluating toxicity
of OTA and degradation products. Teratogenicity was observed at sub-micromolar concentrations
with EC50 as low as 20 nM. This teratogenicity is quantitatively and qualitatively consistent with that
observed in other animal models, but at lower effective concentrations. Along with numerous
practical advantages of zebrafish, these findings support the utility of ZETA, as a rapid, sensitive and
highly informative tool, for investigating toxicity of OTA and its degradative products.
Specifically, the present study confirms, as per previous studies, that OTA is acutely toxic, but
its presumptive degradation product, OTα is generally not toxic. This finding, therefore, further
supports these strategies for detoxifying OTA as a food contaminant. However, continued investigation
of alternative degradation pathways is needed, and the ZETA system will be a useful tool to this end.
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